Page last updated: 2024-12-08

alpha-fluoro-beta-ureidopropionic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

alpha-fluoro-beta-ureidopropionic acid: fluorouracil metabolite; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID151244
CHEMBL ID3544570
CHEBI ID80625
SCHEMBL ID1942706
MeSH IDM0132615

Synonyms (23)

Synonym
alpha-fluoro-beta-ureidopropionic acid
2-fluoro-3-ureidopropionic acid
5006-64-4
fupa
3-(carbamoylamino)-2-fluoropropanoic acid
FT-0664241
unii-0bxg1i9g0w
0bxg1i9g0w ,
propanoic acid, 3-((aminocarbonyl)amino)-2-fluoro-
3-[(aminocarbonyl)amino]-2-fluoro-propanoic acid
SCHEMBL1942706
CHEBI:80625 ,
CHEMBL3544570
AKOS030254459
Q27149673
.beta.-alanine, n-carbamoyl-2-fluoro-
.alpha.-fluorouridopropionic acid
.alpha.-fluoro-.beta.-ureidopropionic acid
n-carbamoyl-2-fluoro-b-alanine
2-fluoro-3-{[hydroxy(imino)methyl]amino}propanoic acid
DTXSID50964507
n-carbamoyl-2-fluoro- beta -alanine
n-carbamoyl-2-fluoro-?-alanine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
organohalogen compoundA compound containing at least one carbon-halogen bond (where X is a halogen atom).
carboxylic acidA carbon oxoacid acid carrying at least one -C(=O)OH group and having the structure RC(=O)OH, where R is any any monovalent functional group. Carboxylic acids are the most common type of organic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Fluoropyrimidine activity015

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (50.00)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.17 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]